Pigment Cell & Melanoma Research

Papers
(The median citation count of Pigment Cell & Melanoma Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease60
An update on Vitiligo pathogenesis58
The enigma and challenges of vitiligo pathophysiology and treatment47
Management of hyperpigmentation: Current treatments and emerging therapies39
Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis37
Rab GTPases: Key players in melanosome biogenesis, transport, and transfer35
An update on the implications of cyclin D1 in melanomas32
Nicotinamide N‐methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines29
The evolution of human skin pigmentation involved the interactions of genetic, environmental, and cultural variables29
Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders27
The role of ferroptosis in melanoma26
Alterations of the pigmentation system in the aging process25
Genetics of non‐syndromic and syndromic oculocutaneous albinism in human and mouse25
The fate of melanocyte: Mechanisms of cell death in vitiligo23
The α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation22
First‐line atezolizumab monotherapy in patients with advanced BRAFV600 wild‐type melanoma22
The tumour immune landscape and its implications in cutaneous melanoma21
Cyclic adenosine monophosphate (cAMP) signaling in melanocyte pigmentation and melanomagenesis21
Strategies in DNA vaccine for melanoma cancer20
The role of technology in melanoma screening and diagnosis20
Emerging strategies to treat rare and intractable subtypes of melanoma20
Identification of melanoma‐specific exosomal miRNAs as the potential biomarker for canine oral melanoma19
Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma19
NRF2‐dependent stress defense in tumor antioxidant control and immune evasion19
The structure and function of the mouse tyrosinase locus18
Dark cyclobutane pyrimidine dimers are formed in the epidermis of Fitzpatrick skin types I/II and VI in vivo after exposure to solar‐simulated radiation16
Cooperative behaviour and phenotype plasticity evolve during melanoma progression16
The effect of aging and antioxidants on photoreactivity and phototoxicity of human melanosomes: An in vitro study16
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells15
HPS11 and OCA8: Two new types of albinism associated with mutations in BLOC1S5 and DCT genes15
Support for increased cardiovascular risk in non‐segmental vitiligo among Egyptians: A hospital‐based, case–control study14
Current landscape of Oculocutaneous Albinism in Japan14
Novel three‐way complex rearrangement of TRPM1‐PUM1LCK in a case of agminated Spitz nevi arising in a giant congenital hyperpigmented macule14
The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment14
Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications13
A Focused review on the pathophysiology of post‐inflammatory hyperpigmentation13
Dhh‐expressing Schwann cell precursors contribute to skin and cochlear melanocytes, but not to vestibular melanocytes13
Human TYRP1: Two functions for a single gene?13
Molecular characterization of SLC24A5 variants and evaluation of Nitisinone treatment efficacy in a zebrafish model of OCA612
Premature senescence in human melanocytes after exposure to solar UVR: An exosome and UV‐miRNA connection12
User guide to MiT‐TFE isoforms and post‐translational modifications12
The unfolded protein and integrated stress response in melanoma and vitiligo12
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo12
Immunotherapy for older patients with melanoma: From darkness to light?11
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma11
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features11
Speed rate (SR) as a new dynamic index of melanoma behavior11
Endothelin signaling promotes melanoma tumorigenesis driven by constitutively active GNAQ11
Vitiligo: Translational research and effective therapeutic strategies11
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transfer10
Phenotypic plasticity of melanocytes derived from human adult skin10
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)10
The MITF regulatory network in melanoma10
The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptome10
Genetic variants and mutational spectrum of Chinese Hermansky–Pudlak syndrome patients9
Non‐invasive optical biopsy by multiphoton microscopy identifies the live morphology of common melanocytic nevi9
Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families9
Drosophila yellow‐h encodes dopaminechrome tautomerase: A new enzyme in the eumelanin biosynthetic pathway9
Melanin‐concentrating hormone like and somatolactin. A teleost‐specific hypothalamic‐hypophyseal axis system linking physiological and morphological pigmentation9
CD147 regulates melanoma metastasis via the NFAT1‐MMP‐9 pathway9
New insights into the pathogenesis of Hermansky–Pudlak syndrome9
Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma9
Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome8
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 20158
Antihypertensives and melanoma: An updated review8
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma8
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation7
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma7
Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma7
Transcriptomic analysis and ednrb expression in cochlear intermediate cells reveal developmental differences between inner ear and skin melanocytes7
Volar location and degree of pigmentation are associated with poor survival and first metastasis pattern in acral melanoma7
Germline loss‐of‐function variants in MBD4 are rare in Finnish patients with uveal melanoma7
Heme oxygenase promotes B‐Raf‐dependent melanosphere formation7
Instant isolation of highly purified human melanocytes from freshly prepared epidermal cell suspensions6
Connexins in melanoma: Potential role of Cx46 in its aggressiveness6
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study6
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy6
The feather pattern autosomal barring in chicken is strongly associated with segregation at the MC1R locus6
Establishment of a mouse model for post‐inflammatory hyperpigmentation6
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation‐induced canities6
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma6
The impaired unfolded protein‐premelanosome protein and transient receptor potential channels‐autophagy axes in apoptotic melanocytes in vitiligo6
Recurrent co‐alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis6
Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma6
Induced pluripotent stem cell‐derived myeloid cells expressing OX40 ligand amplify antigen‐specific T cells in advanced melanoma6
The delicate relation between melanocytes and skin immunity: A game of hide and seek6
A novel BLOC1S5‐related HPS‐11 patient and zebrafish with bloc1s5 disruption6
Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes5
Primary tumor characteristics and next‐generation sequencing mutations as biomarkers for melanoma immunotherapy response5
Abrogation of RAB27A expression transiently affects melanoma cell proliferation5
Presence and the roles of IL‐9/Th9 axis in vitiligo5
Genome‐wide association study identifies CDH13 as a susceptibility gene for rhododendrol‐induced leukoderma5
Investigating DNA methylation as a potential mediator between pigmentation genes, pigmentary traits and skin cancer5
Melanocortin‐1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium‐to‐giant congenital melanocytic nevi5
Systematic review and meta‐analysis of genomic alterations in acral melanoma5
Establishment of cultured primary acral melanoma cells and animal models for Chinese patients4
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL4
Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma4
Pharmacologic manipulation of skin pigmentation4
A B‐cell or a key player? The different roles of B‐cells and antibodies in melanoma4
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment4
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity4
Advancements in melanoma cancer metastasis models4
Eosinophils and melanoma: Implications for immunotherapy4
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance4
Interferon‐gamma induces melanogenesis via post‐translational regulation of tyrosinase4
Myron Gordon Award paper: Microbes, T‐cell diversity and pigmentation4
Novel variants in the BLOC1S3 gene in patients presenting a mild form of Hermansky–Pudlak syndrome4
Transient activation of tumoral DNA damage tolerance pathway coupled with immune checkpoint blockade exerts durable tumor regression in mouse melanoma4
Cell‐intrinsic melanin fails to protect melanocytes from ultraviolet‐mutagenesis in the absence of epidermal melanin3
Genetic predisposition to long telomeres is associated with increased mortality after melanoma: A study of 2101 melanoma patients from hospital clinics and the general population3
Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis3
Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma3
Making a melanoma: Molecular and cellular changes underlying melanoma initiation3
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities3
Generation of Pmel‐dependent conditional and inducible Cre‐driver mouse line for melanocytic‐targeted gene manipulation3
Varicella‐zoster virus in actively spreading segmental vitiligo skin: Pathological, immunochemical, and ultrastructural findings (a first and preliminary study)3
NRASQ61K melanoma tumor formation is reduced by p38‐MAPK14 activation in zebrafish models and NRAS‐mutated human melanoma cells3
Mitochondrial DNA‐depleter mouse as a model to study human pigmentary skin disorders3
Abstracts3
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines3
3
Let’s talk about sex: A biological variable in immune response against melanoma3
Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties3
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features3
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling3
Melanoma toolkit for early detection for primary care providers: A pilot study3
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)2
2
19th International Congress of the Society for Melanoma Research2
Morphological evolution in melanoma in situ using revised pattern analysis2
2
RAC1mutation is not a predictive biomarker for PI3’‐kinase‐β‐selective pathway‐targeted therapy2
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment2
2
NR2F1 regulates a Schwann cell precursor‐vs‐melanocyte cell fate switch in a mouse model of Waardenburg syndrome type IV2
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 62
Trained immunity in the pathogenesis of vitiligo2
Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment2
Influence of germline genetic variants on dermoscopic features of melanoma2
Intragenic NF1 deletions in sinonasal mucosal malignant melanoma2
Donskoy cats as a new model of oculocutaneous albinism with the identification of a splice‐site variant in HermanskyPudlak Syndrome 5 gene2
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants2
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors1
New insights into segmental vitiligo: A clinical and immunological comparison with nonsegmental vitiligo1
1
A twenty year perspective on melanoma therapy1
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa1
Immune‐modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model1
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo1
B6‐Dct‐H2BGFP bitransgenic mice: A standardized mouse model for in vivo characterization of melanocyte development and stem cell differentiation1
Special issue: “Biology of skin pigmentation and pigmentary diseases”1
TFE3 promotes ferroptosis in melanoma1
Genomic analysis of metastatic melanoma in an adult with giant congenital melanocytic nevus1
Clinicopathological features and associations in a series of South African acral melanomas1
Zebrafish as a new model for rhododendrol‐induced leukoderma1
Melanoma literacy among the general population of three western US states1
Senescent no more1
Dysbiosis of skin microbiome in melasma patients1
Undereducation is afoot: Assessing the lack of acral lentiginous melanoma educational materials for skin of color1
Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK)1
Optimisation of skin phototype classification1
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort1
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation1
Increased anti‐oxidative action compensates for collagen tissue degeneration in vitiligo dermis1
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care1
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis1
The immunosuppressive role of Edn3 overexpression in the melanoma microenvironment1
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism1
MITF E318K: A rare homozygous case with multiple primary melanoma1
Protein‐based classification of melanoma differentiation subtypes1
BMI1 is required for melanocyte stem cell maintenance and hair pigmentation1
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy1
Diversity, equity, and inclusion in the melanoma research community1
Role of serine 365 in BRAF V600E sensitivity to RAF inhibition1
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage1
Small extracellular vesicle‐based human melanocyte and melanoma signature1
1
Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line1
Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus1
Proceeding Report of the Second Vitiligo International Symposium—November 9–10, 2018, Detroit, Michigan, USA1
1
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)1
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model1
MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells1
0.13448786735535